Alpha 2.0
Login Register
» Articles » PMID: 33434059

Autologous Stem Cell Transplantation in the Management of Relapsed Non-Hodgkin Lymphoma

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2021 Jan 12
PMID 33434059
Citations 4
Authors
Alvaro J Alencar
Craig H Moskowitz
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of stem cell mobilization with etoposide +cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma.

Zhu Z, Li X, Yuan X, Chen X, Lin T, Guo X Front Immunol. 2024; 15:1439253.

PMID: 39091501 PMC: 11291192. DOI: 10.3389/fimmu.2024.1439253.

Predictors of response to axicabtagene-ciloleucel CAR T cells in aggressive B cell lymphomas: A real-world study.

Iovino L, Wu Q, Voutsinas J, Panaite L, Mullane E, Lynch R J Cell Mol Med. 2022; 26(24):5976-5983.

PMID: 36453136 PMC: 9753434. DOI: 10.1111/jcmm.17550.

Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies.

Wang C, Liu J, Liu Y Front Oncol. 2022; 11:798008.

PMID: 35096597 PMC: 8792758. DOI: 10.3389/fonc.2021.798008.

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma.

Alencar A, Hirayama A, Cle D, Salvino M, Perini G, Arrais C Hematol Transfus Cell Ther. 2021; 43 Suppl 2:S22-S29.

PMID: 34794792 PMC: 8606699. DOI: 10.1016/j.htct.2021.09.003.